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the long-term outcome of STEMI and UAP.
METHODS The study enrolled 46 acute STEMI patients and 89 UAP
patients who accepted successful PCI, and 35 patients without CHD,
and followed up for 2 years. The MACE included cardiovascular death,
recurrent acute myocardial infarction (AMI), readmission for heart
failure or revascularization.
RESULTS The plasma catestatin level in STEMI group (0.800.62
ng/ml) and in UAP group (0.990.62 ng/ml) were signiﬁcantly lower
than that of control group (1.380.98 ng/ml) (p ¼0.001). There were 7
MACEs (readmission for revascularization) in the UAP group, and
there were 8 MACEs (2 recurrent AMI, 3 readmission for revasculari-
zation, and 3 readmission for heart failure) in STEMI group including,
during 2 years follow up after discharge. There were no signiﬁcant
differences between STEMI group and UAP group. The MACEs
occurred at median 13.5 months after discharge. Kaplan – Meier haz-
ard analyses showed that there were no signiﬁcant differences in
MACE between the patients with high level catestatin and low level
catestatin (p¼0.587). In the Cox proportional hazards regression, LVEF
was the only independent predictor for MACE (HR 0.95, p ¼0.029),
catestatin level was not independently associated with MACE.
CONCLUSIONS The plasma catestatin levels in STEMI and UAP pa-
tients were lower than that in the patients without CHD. The catestatin
levels were not related to the MACE among CHD patients. An early
deﬁciency of catestatin might play a pathogenic role in the subsequent
development of acute coronary syndrome. Catestatin is thus emerging
as a very important peptide regulating multiple functions, and iden-
tiﬁcation of the molecular mechanism underlying the protective role
of this peptide may lead to a novel therapeutic option in CHD.
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OBJECTIVES To explore the relationship between the composite in-
dex of the serum bilirubin and serum lipid variables, the serum
ﬁbrinogen(FIB) level and the severity of coronary heart disease. To
investigate whether it is more signiﬁcant for the composite index of
the serum bilirubin and serum lipid variables to predict coronary than
the traditional serum lipid variables, like cholesterol(TC) and low
density lipoprotein cholesterol(LDL-C).
METHODS A total of 324 patients who had undergone coronary
angiography were collected. They were divided into two groups by
their results of coronary angiography :①the group of coronary ar-
tery disease(CAD);②normal. The GENSINI scoring system were used
for determining the severity of coronary artery disease. All of the
patients were divided to 4 groups depending on its results: group
A: <P25; group B:P25-P50; group C:P50-P75 and group D: >P75. The
levels of serum total bilirubin(TBIL), cholesterol(TC), low density
lipoprotein cholesterol(LDL-C), high density lipoprotein cholester-
ol(HDL-C) and ﬁbrinogen(FIB) were measured, at the same time, the
ratio value of TC/(HDL-CþTBIL) and LDL-C/(HDL-CþTBIL) were
calculated.
RESULTS The results of TC, LDL-C, FIB, TC/(HDL-CþTBIL), LDL-C/
(HDL-CþTBIL) has shown signiﬁcant differences (P<0.05) between
CAD group and normal group. Signiﬁcant difference(P<0.05) has
shown in the FIB levels and LDL-C/(HDL-CþTBIL) ratio, TC/(HDL-
CþTBIL) ratio and HDL-C levels, TBIL levels and IBIL levels among
group A, B, C and D. Bivariate analysis shows that the results of TC,
FIB, LDL-C/(HDL-CþTBIL) ratio, TC/(HDL-CþTBIL) ratio positively
correlated with GENSINI score, HDL-C, TBIL and IBIL levels negatively
correlated with the GENSINI score; what’s more, the results showed
that the TBIL levels negatively correlated with the TG levels and LDL-
C levels, simultaneously, the DBIL levels negatively correlated with
the TC and TG levels. The area under the ROC curve of LDL-C/(HDL-
CþTBIL) was 0.801 and the 95% conﬁdence interval of the corre-
sponding area was 0.745-0858. If the pivotal point of diagnosis of CAD
was 0.1643, the speciﬁcity was 81.0%, and the sensitivity was 61.7%.
The area under the ROC curve of TC/(HDL-CþTBIL) was 0.805 and the
95% conﬁdence interval of the corresponding area was 0.751-0.860. If
the pivotal point of diagnosis of CAD was 0.2930, the speciﬁcity was
81.0%, and the sensitivity was 65.6%.CONCLUSIONS The composite index of the serum bilirubin and
serum lipid variables and the serum ﬁbrinogen(FIB) level positively
correlated with the severity of coronary heart disease. Using the
composite index of the serum bilirubin and serum lipid variables to
predict the severity of coronary atherosclerosis is better than tradi-
tional serum lipid variables do.GW26-e1444
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OBJECTIVES This study was to evaluate the association between
atherosclerotic plaque characteristics (APCs) by coronary computed
tomography angiography (CTA), and lesion ischemia by fractional ﬂow
reserve (FFR).
METHODS 252 patients (mean age 63 years; 71% males) underwent
coronary CTA, with FFR performed for 407 coronary lesions. Coronary
CTA was interpreted for <50% and 50% stenosis, with the latter
considered obstructive. APCs by coronary CTA were deﬁned as:
1) positive remodeling (PR), lesion diameter/reference diameter >1.10;
2) low attenuation plaque (LAP), any voxel <30 Hounsﬁeld units; and
3) spotty calciﬁcation (SC), nodular calciﬁed plaque <3 mm. Odds
ratios (OR) and net reclassiﬁcation improvement of APCs for lesion
ischemia, deﬁned by FFR 0.8, were analyzed.
RESULTS By FFR, ischemia was present in 151 lesions (37%). Aggregate
plaque volume (APV) was associated with a 50% increased risk of
ischemia per 5% additional APV. PR, LAP, and SC were associated with
ischemia, with a 3 to 5 times higher prevalence than in nonischemic le-
sions. In multivariable analyses, a stepwise increased risk of ischemia was
observed for 1 (OR: 4.0, p < 0.001) and 2 (OR: 12.1, p < 0.001) APCs.
These ﬁndings were APC dependent, with PR (OR: 5.3, p < 0.001) and
LAP (OR: 2.1, p ¼ 0.038) associated with ischemia, but not SC. When
examined by stenosis severity, PR remained a predictor of ischemia for all
lesions, whereas APV and LAP were associated with ischemia for
only 50%, but not for <50%, stenosis.
CONCLUSIONS APV and APCs by coronary CTA improve identiﬁcation
of coronary lesions that cause ischemia. PR is associated with all
ischemia-causing lesions, whereas APV and LAP are only associated
with ischemia-causing lesions 50%.GW26-e2105
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OBJECTIVES MAFB has been associated with serum lipid levels in
the European population. However, little is known about such
association in the Chinese population or in atherosclerosis-related
patients. Therefore, the purpose of the present study was to
assess the association of the single nucleotide polymorphisms
(SNPs) in the MAFB and serum lipid levels and the risk of coro-
nary artery disease (CAD) and ischemic stroke (IS) in the Chinese
population.
METHODS A total of 1,065 unrelated patients (CAD, 525 and IS,
540) and 539 healthy controls were recruited in this study. Coro-
nary angiography was performed in patients with CAD. CAD was
deﬁned as signiﬁcant coronary stenosis (>50%) in at least either
one of the three main coronary arteries or their major branches
(branch diameter >2 mm). The classiﬁcation of IS was made ac-
cording to the TOAST (Trial of Org 10172 in Acute Stroke Treat-
ment) criteria. The selected IS patients in the study included
individuals who were eligible for one of the two subtypes of
TOAST criteria: Large-artery atherosclerosis and small-vessel oc-
clusion. Subjects with a history of hematologic, neoplastic, renal,
liver, thyroid, autoimmune diseases and type I diabetes mellitus
were excluded. The selected IS patients who had a past history of
CAD were excluded, while the selected CAD patients who had a
past history of IS were excluded from the study. Genotypes of the
